Press releases - Archives
- March 11, 2008 - Advitech presents a management's strategic update and review (PDF 33 Ko)
- February 14, 2008 - Advitech: A second preclinical study with positive results for wound healing (PDF 85 Ko)
- December 18, 2007 - Advitech signs a definitive distribution agreement for Mexico with a pharmaceutical leader in dermatology (PDF 32 Ko)
- December 6, 2007 - The wound healing platform generates a first commercial partnership for advitech. (PDF 32 Ko)
- December 4, 2007 - Advitech announces that Dermylex™ is now available under the Psopax® brand name in france and belgium. (PDF 28 Ko)
- November 29, 2007 - Advitech announces highlights and financial results for third quarter 2007. (PDF 124 Ko)
- October 10, 2007 - Advitech announces positive preclinical results for wound-healing application. (PDF 28 Ko)
- October 1, 2007 - Effectiveness of Dermylex™ supported by new results as Psoriasis Month kicks off across Canada. (PDF 24 Ko)
- September 12, 2007 - Advitech announces new efficacy results for Dermylex™ and compliance with FDA regulations on claims. (PDF 28 Ko)
- August 29, 2007 - Advitech announces results for its second quarter. (PDF 200 Ko)
- July 31, 2007 - Advitech has concluded a worldwide licensing agreement with Diversified Natural Products. (PDF 32 Ko)
- June 27, 2007 - Advitech announces a definitive distribution agreement of Dermylex™ for France and Belgium. (PDF 32 Ko)
- June 14, 2007 - Advitech announces an exclusive distribution agreement for Dermylex™ to the U.S. Market. (PDF 32 Ko)
- May 11, 2007 - Advitech announces results for its first quarter and provides an update on its recent developments, an outlook and the appointment of new board members. (PDF 156 Ko)
- May 2, 2007 - Advitech announces the closing of a $970,000 private placement with Agechem and new payment terms for its 2004 convertible debentures. (PDF 48 Ko)
- April 13, 2007 - Advitech inc announces an agreement with Maxi Healthcare for the distribution of Dermylex™ in Indonesia and its annual general meeting (PDF 104 Ko)
- April 5, 2007 - Advitech announces an agreement with a pharmaceutical company for France and Belgium Concerning its psoriasis product Dermylex™ (PDF 96 Ko)
- April 4, 2007 - Advitech reports its fourth quarter and year-end 2006 results (PDF 108 Ko)
- April 2, 2007 - Advitech announces the closing of an $885,000 private placement and a new stock option grant (PDF 96 Ko)
- March 1st, 2007 - Advitech announces its intention to proceed to financing by way of private placements and the appointment of an investors' relations consultant (PDF 93 Ko)
- February 15, 2007 - Advitech announces a $ 500,000 private placement with Capital Financiere Agricole Inc. (PDF 94 Ko)
- February 5, 2007 - Advitech appoints Mr. François Courteau as vice-president and chief operating officer (PDF 98 Ko)
- January 15, 2007 - Jamieson announces nationwide distribution of breakthrough psoriasis remedy Dermylex? (PDF 95 Ko)
- December 22, 2006 - Advitech's XP-828L process granted U.S. patent (PDF 92 Kb)
- December 19, 2006 - Advitech announces a $ 515 800 private placement and a definitive agreement with Enbio-Life Biotech for the Taiwan market (PDF 108 Kb)
- November 16, 2006 - Celebrated former Canadian olympian Pierre Harvey to promote Advitech's Dermylex™ product (PDF 95 Kb)
- October 26, 2006 - Advitech announces its first significant Dermylex™ sales and its 2006 third-quarter financial results (PDF 134 Kb)
- October 10, 2006 (from Jamieson Laboratories) - Clinical trials demonstrate nutritional supplement's ability to relieve psoriasis symptoms (PDF 74 Kb)
- September 27, 2006 - Advitech announces a revised agreement with Jouan Biotechnologies and a change of distributor for the U.S. market (PDF 141 Kb)
- September 6, 2006 - Advitech annonces stock option grants (PDF 171 Kb)
- August 23, 2006 - Advitech announces its second-quarter highlights and financial results for 2006 (PDF 111 Kb)
- August 8, 2006 - Advitech annouces positive results for a third application oh the XP-828L platform and publication of a second scientific paper on Dermylex (PDF 104 Kb)
- July 11, 2006 - Advitech announces new efficacy results for the treatment of psoriasis with Dermylex (PDF 102 Kb)
- June 29, 2006 - Advitech announces changes in management staff (PDF 25 Kb)
- June 22, 2006 - Advitech announces the signing of a definitive agreement with Jamieson Laboratories for the distribution of Dermylex™ in Canada and additional interim financing (PDF 25 Kb)
- June 12, 2006 - Advitech announces the signing of a definitive agreement on the distribution of Dermylex™ in France and the interim financing (PDF 105 Kb)
- May 5, 2006 - Advitech announces its first-quarter highlights and financial results (PDF 105 Kb)
- April 26, 2006 - Advitech Inc announces agreement with Enbio-Life for Dermylex™ in Taiwan (PDF 85 Kb)
- March 9, 2006 - Advitech announces the introduction of Dermylex™ in Toronto and Quebec City and agreement with Jamieson Laboratories (PDF 97 Kb)
- March 2, 2006 - Advitech announces that Cothera confirms the introduction of Dermylex™ in France (PDF 19 Kb)
- February 23, 2006 - Adviteh's Dermylex™ will be marketed by PhotoMedex in five U.S. area by the end of February 2006 and will be presented at the American Academy of Dermatology Conference in San Francisco on March 2-6, 2006 Dermylex™ will be presented to 10.000 dermatologists. (PDF 23 Kb)
- February 3rd, 2006 - Advitech announces a mandate to group CRÉA and administrative changes (PDF 20 Kb)
- January 12, 2006 - Advitech announces agreement for its Psoriasis product Dermylex with Photomedex for th US market (PDF 115 Kb)
- December 16, 2005 - Advitech appoints Ms. Christina Juneau as Vice-President Research and Development (PDF 32 Kb)
- December 15, 2005 - Advitech announces agreement with Cothera to market its psoriasis product in France (PDF 37 Kb)
- October 26, 2005 - Advitech announces its third-quarter highlights and financial results. 2nd application for its XP-828L platform (PDF 124 Kb)
- October 6, 2005 - New potential treatment for inflammatory bowel diseases: Advitech announces positive results from preclinical study (PDF 96 Kb)
- October 3, 2005 *- Advitech to communicate the results of its study on inflammatory bowel diseases october 6, at Biocontact 2005 (PDF 56 Kb)
- September 28, 2005 - Advitech announces the eligibility of its common shares to the SME Growth Stock Plan (PDF 56 Kb)
- September 14, 2005 - Advitech provides update on its recent developments and upcoming milestones (PDF 108 Kb)
- August 24, 2005 - Advitech announces its second-quarter highlights and financial results (PDF 150 Kb)
- July 13, 2005 - Advitech steps up marketing program for new oral psoriasis product (PDF 32 Kb)
- July 5, 2005 - Advitech announces positive results of XP-828L study in psoriasis (PDF 128 Kb) br>
- June 15, 2005 - Advitech announces completion of its 2nd study on XP-828L for treating psoriasis (PDF 92 Kb)
- June 6, 2005 - Echoes Financial Network Inc. to provide investor relations services to Advitech with ROADSHOWS.TV (PDF 85 Kb)
- May 4, 2005 - Advitech announces its first-quarter highlights and financial results (PDF 144 Kb)
- March 24, 2005 - Advitech reports its fourth quarter and year-end 2004 results (PDF 260 Kb)
- March 23, 2005 - Renaud Beauchesne, President and CEO of Advitech to present at BIOMATCH 2005 (PDF 95 Kb)
- February 21, 2005 - Advitech and CHUL research center to test xp-828l for the treatment of inflammatory bowel diseases (PDF 20 Kb)
- February 14, 2005 - Advitech completes recruitement for its second clinical study on oral treatment for psoriasis (PDF 8 Kb)
- February 1, 2005 - Advitech to present study findings on XP-828L at the American Academy of Dermatology Congress (PDF 116 Kb)
- January 27, 2005 - Advitech reinforces its intellectual property position: granted important patent (PDF 120 Kb)
- November 9, 2004 - Advitech receives Health Canada authorization to begin a double-blind, placebo-controlled clinical study on a new oral psoriasis treatment (PDF 120 Kb)
- November 9, 2004 - Key additions to Advitech's scientific team (PDF 128 Kb)
- November 3, 2004 - Advitech reports its third quarter results and highlights (PDF 68 Kb)
- October 14, 2004 - Advitech to present at European Psoriasis Congress (PDF 12 Kb)
- September 20, 2004 - Advitech appoints Jean-Luc Martre vice-president sales and marketing (PDF 22 Kb)
- September 13, 2004 - Advitech announces appointment of Mr Andre Lamothe to its board of directors (PDF 12 Kb)
- September 9, 2004 - Dr. Georges M. Halpern joins Advitech scientific advisory board (PDF 26 Kb)
- August 31, 2004 - Advitech announces promising results from open clinical study on new oral psoriasis treatment (PDF 24 Kb)
- August 26, 2004 - Advitech reports its second quarter results and highlights (PDF 192 Kb)
- July 13, 2004 - Advitech announces closing of $2.8 million public offering (PDF 118 Kb)
- July 5, 2004 - Advitech Inc. files final prospectus for a 2.5 million dollar financing (PDF 12 Kb)
- June 25, 2004 - Dupont Capital Inc. and Advitech Solutions Inc. file an amended preliminary prospectus (PDF 48 Kb)
- June 10, 2004 - Advitech to present results on new treatment for psoriasis at International Psoriasis Symposium (PDF 15 Kb)
- May 26, 2004 - Advitech Solutions reports positive interim results on new treatment for psoriasis (PDF 20 Kb)
- May 26, 2004 - Dupont Capital Inc. and Advitech Solutions Inc. file a preliminary prospectus (PDF 20 Kb)
- May 19, 2004 - Dupont Capital Inc. announces qualifying transaction with Advitech Solutions Inc. (PDF 128 Kb)
- March 16, 2004 - Dupont Capital Inc. announces proposed qualifying transaction with Advitech Solutions Inc. (PDF 188 Kb)